SCHEMBL2932612

SCHEMBL2932612

CC(C)(C)OC(=O)ON1CCC2(CC1)NC(=O)[C@H](Cc1ccccc1)N2

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.35
PLA2G10 O15496 1/20 0.35
PLA2G5 P39877 1/20 0.35
ALDH1A1 P00352 3/20 0.35
LMNA P02545 3/20 0.35
KLK7 P49862 2/20 0.35
STS P08842 1/20 0.35
KLK5 Q9Y337 1/20 0.35
HDAC8 Q9BY41 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HDAC4 P56524 2/20 0.34
HDAC1 Q13547 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MEN1 O00255 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4037006 1.00 KMT2A (0.35) KMT2APLA2G10PLA2G5ALDH1A1LMNA
SCHEMBL1801632 0.85 OPRD1 (0.45) LMNASTSSMN1; SMN2
SCHEMBL3920513 0.85 OPRD1 (0.45) LMNASTSSMN1; SMN2
SCHEMBL2940834 0.79 CXCR3 (0.38) KMT2APLA2G10PLA2G5STS
SCHEMBL4039209 0.79 CXCR3 (0.38) KMT2APLA2G10PLA2G5STS
SCHEMBL4037642 0.79 HDAC8 (0.34) HDAC8
SCHEMBL2941098 0.79 HDAC8 (0.34) HDAC8
SCHEMBL1801535 0.78 GAA (0.51) KMT2AALDH1A1LMNAHDAC8SMN1; SMN2
SCHEMBL2936432 0.78 GAA (0.51) KMT2AALDH1A1LMNAHDAC8SMN1; SMN2
SCHEMBL1800257 0.78 KMT2A (0.41) KMT2AALDH1A1LMNAHDAC8SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730147-B1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4,5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY GRUENENTHAL GMBH (DE) 2010-02-03 EP disclosed
WO-2005095402-A9 SUBSTITUTED 1,4,8-TRIAZASPIRO[4.5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY GRUENENTHAL GMBH (DE) 2009-06-11 WO disclosed
EP-1730147-A1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4,5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY Grünenthal GmbH (DE) 2006-12-13 EP disclosed
WO-2005095402-A1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4.5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY Grünenthal GmbH (DE) 2005-10-13 WO disclosed